Here are four things to know:
1. The registry is comprised of patients who have received implants of GRAFTYS HBS and GRAFTYS QuickSet.
2. Both the GRAFTYS HBS and GRAFTYS QuickSet are advanced phosphocalcic cements that are highly injectable and resorbable.
3. The goal of establishing the registry is to systematically validate short term and long term clinical results for implantable devices after product launch.
4. GRAFTYS cements can be used in numerous applications, such as bone marrow lesions in the knee.
More articles on devices:
SeaSpine Q3 revenue drops 3%, net loss hits $133M: 5 key notes
Amedica revenue drops 19% in Q3: 5 things to know
VertiFlex, Xtant Medical, Orthofix & more — 23 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
